Search for Clinical Trial Results
Focal Segmental Glomerulosclerosis - 27 Studies Found
Status | Study |
Terminated |
Study Name: Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS) Condition: Focal Segmental Glomerulosclerosis Date: 2008-10-27 Interventions: Drug: FG-3019 FG-3019 5 mg/kg IV given over 2 hours every 2 weeks for 8 weeks |
Terminated |
Study Name: Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis Condition: Focal Segmental Glomerulosclerosis Date: 2009-08-10 Interventions:
|
Completed |
Study Name: Permeability Factor in Focal Segmental Glomerulosclerosis Condition: Focal Segmental Glomerulosclerosis Date: 2000-12-22 Interventions:
|
Terminated |
Study Name: Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor Condition: Focal Segmental Glomerulosclerosis Date: 2008-12-31 Interventions: Drug: Galactose Oral galactose, 0.2 g/kg/dose twice daily for 28 days |
Recruiting |
Study Name: Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis) Condition: Focal Segmental Glomerulosclerosis Date: 2015-03-03 Interventions: Biological: Intravenous injection Intravenous injection of AD-MSC to the patients with FSGS |
Active, not recruiting |
Study Name: Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis Condition: Focal Segmental Glomerulosclerosis Date: 2012-06-04 Interventions:
|
Completed |
Study Name: Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS Condition: Focal Segmental Glomerulosclerosis Date: 2007-04-20 Interventions:
|
Completed |
Study Name: Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT) Condition: Glomerulosclerosis, Focal Date: 2005-08-24 Interventions:
|
Recruiting |
Study Name: Genetic Markers for Focal Segmental Glomerulosclerosis Condition:
|